Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($) $ in Thousands |
12 Months Ended | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
Sep. 30, 2024 |
Jun. 30, 2024 |
Mar. 31, 2024 |
Sep. 30, 2023 |
Jun. 30, 2023 |
Mar. 31, 2023 |
Sep. 30, 2022 |
Jun. 30, 2022 |
Mar. 31, 2022 |
|||
| Class of Stock [Line Items] | ||||||||||||||
| Cash and cash equivalents | $ 59,659 | $ 446,616 | $ 52,675 | $ 64,938 | $ 61,456 | $ 59,505 | $ 56,793 | $ 58,854 | $ 45,880 | $ 50,617 | $ 94,054 | $ 87,014 | ||
| Deferred tax assets recorded | 103,205 | 98,304 | 89,293 | |||||||||||
| Valuation allowance | [1] | 181,962 | 84,334 | 50,149 | ||||||||||
| Advertising costs | 30,600 | 24,600 | 23,900 | |||||||||||
| Research and development expense | 16,900 | 13,900 | 11,700 | |||||||||||
| Total employer contributions to plans | 5,300 | 4,600 | 4,200 | |||||||||||
| Share-based Payment Arrangement, Expense | 16,300 | 9,500 | $ 10,500 | |||||||||||
| Stock compensation expense in future years for unvested options | $ 55,600 | |||||||||||||
| Business Acquisitions | ||||||||||||||
| Class of Stock [Line Items] | ||||||||||||||
| Share of the voting interest percentage | 50.00% | |||||||||||||
| Foreign | Subsidiaries | ||||||||||||||
| Class of Stock [Line Items] | ||||||||||||||
| Cash and cash equivalents | $ 24,100 | $ 21,500 | ||||||||||||
| ||||||||||||||
| X | ||||||||||
- Definition Defined contribution plan employer contribution amount. No definition available.
|
| X | ||||||||||
- Definition Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Percentage of voting equity interests acquired at the acquisition date in the business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of cost to be recognized for option under share-based payment arrangement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|